Prosím čekejte...
Nepřihlášený uživatel
Nacházíte se: VŠCHT PrahaFCHTÚstav chemie pevných látek  → Věda a výzkum → Pracovní skupiny → Aplikace RTG difrakčních metod ve farmaceutickém výzkumu, vývoji, výrobě a kontrole → Výběr publikací skupiny aplikace rtg. difrakčních metod ve farmaceutickém průmyslu
iduzel: 23123
idvazba: 29228
šablona: stranka
čas: 28.3.2024 20:28:53
verze: 5378
uzivatel:
remoteAPIs:
branch: trunk
Server: 147.33.89.150
Obnovit | RAW
iduzel: 23123
idvazba: 29228
---Nová url--- (newurl_...)
domena: 'uchpel.vscht.cz'
jazyk: 'cs'
url: '/veda-a-vyzkum/pracovni_skupiny/aplikace_rtg/publikace_rtg'
iduzel: 23123
path: 8548/22498/22499/22502/22587/22602/22753/23123
CMS: Odkaz na newurlCMS
branch: trunk
Obnovit | RAW

Výběr publikací skupiny aplikace rtg. difrakčních metod ve farmaceutickém průmyslu

Nievergelt, P. P.; Babor, M.; Cejka, J.; Spingler, B. A high throughput screening method for the nano-crystallization of salts of organic cations. Chemical Science 2018 9(15), 3716-3722.

Dolensky, B.; Kessler, J.; Jakubek, M.; Havlik, M.; Cejka, J.; Novotna, J.; Kral, V., Synthesis and characterisation of a new naphthalene tris-Troger's base derivative-a chiral molecular clip. Tetrahedron Letters 2013, 54, 308-311.

Skorepova, E.; Cejka, J.; Husak, M.; Eigner, V.; Rohlicek, J.; Sturc, A.; Kratochvil, B., Trospium Chloride: Unusual Example of Polymorphism Based on Structure Disorder. Crystal Growth & Design 2013, 13, 5193-5203.

Urbanova, M.; Sturcova, A.; Brus, J.; Benes, H.; Skorepova, E.; Kratochvil, B.; Cejka, J.; Sedenkova, I.; Kobera, L.; Policianova, O.; Sturc, A., Characterizing crystal disorder of trospium chloride: A comprehensive,13C CP/MAS NMR, DSC, FTIR, and XRPD study. Journal of Pharmaceutical Sciences 2013, 102, 1235-1248.

Skorepova, E.; Husak, M.; Cejka, J.; Zamostny, P.; Kratochvil, B., Increasing dissolution of trospium chloride by co-crystallization with urea. Journal of Crystal Growth 2014, 399, 19-26.

Pazout R., Maixner., Dusek M., Kratochvil B.: A new polymorph of succinylcholinium diiodide: comparison of succinylcholinium structures. Acta Crystallogr C 67 (2011), O391-O393.

Kratochvil B., Koupilova I.: Pharmaceutical amorphous hydrates. Chem Listy 105 (2011), 3-7.

Kratochvil B.: Solid forms of pharmaceutical molecules. In: Glassy, amorphous and disordered materials: thermal physics, analysis, structure and properties. (Jaroslav Sestak, Jiri J. Mares and Pavel Hubik Eds.). Springer Verlag.

Okavoca L., Vetchy D., Franc A., Rabiskova M., Kratochvil B.: Increasing bioavailability of poorly water-soluble drugs by their modification. Chem Listy 104 (2010), 21-26.

Kratochvil B., Husak M., Brynda J. et al.: What Can the Current X-Ray Structure Analysis Offer? Chem listy 102 (2008), 889-901. 

Hajkova M., Kratochvil B., Radl S.: Atorvastatin - the world´s best selling drug. Chem Listy 102 (2008), 3-14.

Kratochvil B.: Crystallization of Pharmaceutical Substances. Chem listy 101 (2007), 3-12.

Jegorov A., Petrickova H., Kratochvil B., Cisarova I.: An unusual cis-dichloro[17-(cyclobutylmethyl)3-methoxymorphinan-14-ol- N,O] palladium(II) complex. Collect Czech Chem C 71 (2006), 434-442.

Chudik M., Jegorov A., Petrickova H., Kratochvil B., Cisarova I.: Crystal structure of 3-benzoylmorphin-6-one-17-carboxamide ethanol solvate (1 : 0.333), C24H20N2O5 center dot 0.333C(2)H(5)OH. Z Krist-New Cryst St 220 (2005), 348-350.

Kratochvil B.: Crystal lattice - What with it? Chem Listy 99 (2005), 258-259.

Kratochvil B., Belohlav Z.: Involvement of Institute of Chemical Technology Prague in the research and manufacturing of pharmaceuticals. Chem Listy 98 (2004), 1140-1142. 

Kratochvil B., Husak M., Jegorov A.: Polymorphism and solvatomorphism of solid substances in pharmacy.Chem listy 96 (2002), 330-335.

Kamenicek J., Valach F., Kratochvil B., Zak Z.: Syntheses and structure of Ni(III) complexes with 1-toluene-3,4-dithiole. Bond-valence approach to the oxidation state of the central atom. Pol J Chem 76(2002), 483-490.

Krarochvil B., Husak M., Jegorov A.: Conformational flexibility of cyclosporins. Chem Listy 95 (2001), 9-17.

Pohl R., Sykora J., Malon P., Bohm S., Kratochvil B., Kuthan J.: Sterically crowded heterocycles. XIII. An insight into the absolute stereochemistry of atropisomeric (Z)-3-(imidazo[1,2-a]pyridin-3-yl)prop-2-en-1-ones.Collect Czech Chem C 65 (2000), 1643-1652.

Kratochvil B., Jegorov A., Pakhomova S., Husak M., Bulej P., Cvak L., Sedmera P., Havlicek V.: Crystal structures of cyclosporin derivatives: O-acetyl-(4R)-4-(E-2-butyl)-4,N-dimethyl-L-threonyl-cyclosporin A and O-acetyl-(4R)-4-[E-2-(4-bromobutyl)]-4,N-dimethyl-L-threonyl-cyclosporin A. Collect Czech Chem C 64(1999), 89-98.

Pakhomova S., Kratochvil B., Lellek V., Stibor I.: Methyl 3 ',6 '-bis(chloromethyl)-2,2 '-dimethoxy-1,1 '-binaphthalene-3-carboxylate. Acta Crystallogr 53 (1997), 1871-1873.

Cvak L., Jegorov A., Pakhomova S., Kratochvil B., Sedmera P., Havlicek V., Minar J.: 8 alpha-hydroxy-alpha-ergokryptine, an ergot alkaloid. Phytochemistry 44 (1997), 365-369.

Cvak L, Minar J, Pakhomova S, Ondracek J, Kratochvil B, Sedmera P, Havlicek V, Jegorov A.:  Ergoladinine, an ergot alkaloid. Phytochemistry 42 (1996), 231-233.

Husak M., Gabriel R.: Case Study of Polymorphic Transformation. Chem Listy 105 (2011), 381-384.

Husak M., Kratochvil B., Jegorov A. et al.: Simvastatin: Structure Solution of Two New Low-Temperature Phases from Synchrotron Powder Diffraction and ss-NMR. Struct Chem 21 (2010), 511-518.

Husak M., Jegorov A., Brus J. et al.: Metergoline II: Structure Solution from Powder Diffraction Data with Preferred Orientation and from Microcrystal. Struct Chem 19 (2008), 517 - 525.

Husak M., Rohlicek J., Cejka J., Kratochvil B.: Structure determination from powder diffraction data - It is unrealizable dream or daily use? Chem Listy 101 (2007), 697-705.

Jegorov A., Cvak L., Bednar R., Cejka J., Husak M., Kratochvil B., Cisarova I.: Structures of cabergoline anhydrate form II and novel cabergoline solvates. Struct Chem 17 (2006), 131-137.

Husak M., Kratochvil B., Cisarova I. et al.: Crystal structure of (1-ethoxycarbonyl-pentadecyl)-trimethyl ammonium bromide, (C21H44NO2)Br, form I. Z Krist - New Cryst St 219 (2004), 439 - 441.

Bulej P., Kuchar M., Husak M., Kratochvil B., Jegorov A.: Crystal structure of 4-(2 ',4 '-difluorobiphenyl-4-yl)-2-methylbutanoic acid, F2C16H15COOH, deoxoflobufen. Z Krist - New Cryst St 219 (2004), 297-298.

Husak M., Kratochvil B., Cisarova I., Cvak L., Jegorov A., Bohm S.: Crystal forms of semisynthetic ergot alkaloid terguride. Collect Czech Chem C 67 (2002), 479-489.

Husak M., Kratochvil B., Cisarova I., Jegorov A.: Crystal structures of two new cyclosporin clathrates.Collect Czech Chem C 65 (2000), 1950-1958.

Jegorov A., Cvak L., Husek A., Simek P., Heydova A., Ondracek J., Pakhomova S., Husak M., Kratochvil B., Sedmera P., Havlicek V.: Synthesis and crystal structure determination of cyclosporin H. Collect Czech Chem C 65 (2000), 1317-1328.

Jegorov A., Pakhomova S., Husak M., Kratochvil B., Zak Z., Cvak L., Buchta M.: Cyclosporins of symmetry P2(1) - a series of clathrates. J Incl Phenom Macro 37 (2000), 137-153.

Husak M., Kratochvil B., Jegorov A.: Crystal structure of ergometrine ethyl acetate solvate (2 : 1), (C19H23N3O2)(2)(C4H8O2). Z Krist - New Cryst St 213 (1998), 195-196.

Husak M., Kratochvil B., Sedmera P., Havlicek V., Votavova H., Cvak L., Bulej P., Jegorov A.: Molecular structure of cis- and trans-tergurides. Collect Czech Chem C 63 (1998).

Husak M., Kratochvil B., Buchta M., Cvak L., Jegorov A.: Crystal structure of cyclosporin E. Collect Czech Chem C 63 (1998), 115-120.

Rohlíček J., Hušák M.: MCE2005 – a new version of a program for fast interactive visualization of electron and similar densitymaps optimized for small molecules. J Appl Crystallogr 40 (2007), 600-601.

Rohlicek J., Maixner J., Pazout R. et al.: Alaptide from Synchrotron Powder Diffraction Data. Acta Crystallogr E 66 (2010), O821-U2229.

Rohlicek J., Husak M., Kratochvil B. et al.: Methylergometrine Maleate from Synchrotron Powder Diffraction Data. Acta Crystallogr E 65 (2009), O3252-U1981.

Rohlicek J., Husak M., Gavenda A. et al.: Capecitabine from X-Ray Powder Synchrotron Data. Acta Crystallogr E 65 (2009), O1325-U2267.

Dolensky B., Kvicala J., Paleta O., Lang J., Dvorakova H., Cejka J.:  Trifluoromethylated (tetrahydropyrrolo) quinazolinones by a new three-component reaction and facile assignment of the regio- and stereoisomers formed by NMR spectroscopy. Magn Reson Chem 48 (2010), 375-385.

Tatar A., Cejka J., Kral V., Dolensky B.: Spiro Troger's Base Derivatives: Another Structural Phoenix? Org Lett 12 (2010), 1872-1875.

Sergeyev S., Stas S., Remacle A., Velde CMLV, Dolensky B., Havlik M., Kral V., Cejka J.: Enantioseparations of non-benzenoid and oligo-Troger's bases by HPLC on Whelk O1 column. Tetrahedron-Asymmetr 20 (2009), 1918-1923. 

Valik M., Cejka J., Havlik M., Kral V., Dolensky B.: Calix-Tris-Troger's bases - a new cavitand family.Chem Commun 37 (2007), 3835-3837.

Jegorov A., Cvak L., Bednar R., Cejka J., Husak M., Kratochvil B., Cisarova I.: Structures of cabergoline anhydrate form II and novel cabergoline solvates. Struct Chem 17 (2006), 131-137.

Cejka J., Kratochvil B., Cvak L. et al.: Crystal structure of 2-bromo-1 '-alpha beta-dehydro-ergokryptam acetone sesquisolvate, C32H38BrN5O4 center dot 1.5 (CH3)(2)CO. Z Krist - New Cryst St 220 (2005), 345-347.

Klepetarova B., Cejka J., Kratochvil B., Pakhomova S., Cisakova I., Cvak L., Jegorov A.: Interesting solvent area in crystal structures of two natural ergot alkaloids. Collect Czech Chem C 70 (2005), 41-50.

Cejka J., Kratochvil B., Cisarova I. et al.: Simvastatin. Acta Crystallogr C 59 (2003), O428-O430.

Cejka J., Kratochvil B., Bohm S. et al.: Structural Study of Dopamine Agonist Lisuride. Collect Czech Chem C 68 (2003), 2150-2158.

Petrickova H., Cejka J., Husak M., Kratochvil B., Cisarova I., Jegorov A., Cvak L.: Structure types of dihydroergotoxine mesylates. Collect Czech Chem C 67 (2002), 490-501.

Curinova P., Pojarova M., Budka J., Lang K., Stibor I., Lhotak P.: Binding of neutral molecules by p-nitrophenylureido substituted calix[4]arenes. Tetrahedron 66 (2010), 8047-8050.

Holakovsky R., Pojarova M., Dusek M., Cejka J., Cisarova I.: (R)-2,2 '-Bis[N '-(3,5-dichlorophenyl)ureido]-1,1 '-binaphthalene chloroform disolvate. Acta Crystalogr E - Structure Reports Online 67 (2011), O384-U806.

Kundrat O., Dvorakova H. Cisarova I., Pojarova M., Lhotak P.: Unusual Intramolecular Bridging Reaction in Thiacalix[4]arene Series. Org Lett 11 (2009), 4188-4191.

Machar A., Kozmik V., Pojarova M. et al.: Preparation and Rearrangement Study of Novel Thiophenium- and Selenophenium-Ylides. Collect Czech Chem C 74 (2009), 785-798.

Kundrat O., Cisarova I., Bohm S., Pojarova M., Lhotak P.: Uncommon Regioselectivity in Thiacalix[4]arene Formylation. J Org Chem 74 (2009), 4592-4596.

Kroupa J., Stibor I.,Pojarova M. Tkadlecova M., Lhotak P.: Anion receptors based on ureido-substituted thiacalix[4]arenes and calix[4]arenes. Tetrahedron 64 (2008), 10075-10079.

Lhotak P., Bila A., Budka J., Pojarova M., Stibora I.: Simple synthesis of calix[4]arenes in a 1,2-alternate conformation. Chem Commun 14 (2008), 1662-1664. 

Lang K., Proskova P., Kroupa J., Moravek J., Stibor I., Pojarova M., Lhotak P.: The synthesis and complexation of novel azosubstituted calix[4]arenes and thiacalix[4]arenes. Dyes Pigments 77 (2008), 646-652.

Pojarova M., Kaufmann D., Gaspar R., Nishino T., Reszka P., Bednarski P.J., von Angerer E.: [(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis. Bioorgan Med Chem 15 (2007), 7368-7379.

Pojarova M., Ananchenko G.S., Udachin K.A. et al.: Alpha-C=O Provides Access to the Cavity in Acyl Calix[4]arenes Nanocapsules. New J Chem 31 (2007), 871-878.

Ananchenko G.S., Udachin K.A., Pojarova M. et al.: Van der Waals Nanocapsuler Complexes of Amphiphilic Calixarenes. Cryst Growth Des 6 (2006), 2141-2148.

Seilerova L., Brusova H., Kratochvil B.: Polymorphs and Other Solid Forms of Pharmaceutical Excipients.Chem Listy 105 (2011), 438-444.

Eliška Skořepová, Jan Čejka, Michal Hušák, Václav Eigner, Jan Rohlíček, Antonín Šturc, and Bohumil Kratochvíl.: Trospium Chloride: Unusual Example of Polymorphism Based on Structure Disorder. Crystal Growth & Design 2013 13 (12), 5193-5203

M. Urbanova, A. Sturcova, J. Brus, H. Benes, E. Skorepova, B. Kratochvil, et al. Characterizing crystal disorder of trospium chloride: A comprehensive,13C CP/MAS NMR, DSC, FTIR, and XRPD study. J. Pharm. Sci. (2013).

Menova, P.; Eigner, V.; Cejka, J.; Dvorakova, H.; Sanda, M.; Cibulka, R., Synthesis and structural studies of flavin and alloxazine adducts with O-nucleophiles. Journal of Molecular Structure 2011, 1004, 178-187.

Skalicka, V.; Rybackova, M.; Skalicky, M.; Kvicalova, M.; Cvacka, J.; Brezinova, A.; Cejka, J.; Kvicala, J., Polyfluoroalkylated tripyrazolylmethane ligands: Synthesis and complexes. Journal of Fluorine Chemistry 2011, 132, 434-440.

Dolensky, B.; Kessler, J.; Jakubek, M.; Havlik, M.; Cejka, J.; Novotna, J.; Kral, V., Synthesis and characterisation of a new naphthalene tris-Troger's base derivative-a chiral molecular clip. Tetrahedron Letters 2013, 54, 308-311.

Klecka, M.; Pohl, R.; Cejka, J.; Hocek, M., Direct C-H sulfenylation of purines and deazapurines. Organic & Biomolecular Chemistry 2013, 11, 5189-5193.

Skorepova, E.; Cejka, J.; Husak, M.; Eigner, V.; Rohlicek, J.; Sturc, A.; Kratochvil, B., Trospium Chloride: Unusual Example of Polymorphism Based on Structure Disorder. Crystal Growth & Design 2013, 13, 5193-5203.

Urbanova, M.; Sturcova, A.; Brus, J.; Benes, H.; Skorepova, E.; Kratochvil, B.; Cejka, J.; Sedenkova, I.; Kobera, L.; Policianova, O.; Sturc, A., Characterizing crystal disorder of trospium chloride: A comprehensive,13C CP/MAS NMR, DSC, FTIR, and XRPD study. Journal of Pharmaceutical Sciences 2013, 102, 1235-1248.

Hanzlova, E.; Navratil, R.; Cejka, J.; Boehm, S.; Martinu, T., Evidence for the Cyclic CN2 Carbene in Solution. Organic Letters 2014, 16, 852-855.

Kvapilova, H.; Eigner, V.; Hoskovcova, I.; Tobrman, T.; Cejka, J.; Zalis, S., Structural flexibility of 2-hetaryl chromium aminocarbene complexes: Experimental and theoretical evidence. Inorganica Chimica Acta 2014, 421, 439-445.

Skorepova, E.; Husak, M.; Cejka, J.; Zamostny, P.; Kratochvil, B., Increasing dissolution of trospium chloride by co-crystallization with urea. Journal of Crystal Growth 2014, 399, 19-26.

Šimek M., Grünwaldová V., Kratochvíl B.: A new way of solid dosage form samples preparation for SEM and FTIR using microtome, Pharm. Dev. Technol. 2014, 19 (4) 411–416.

Šimek M., Grünwaldová V., Kratochvíl B.: Current Methods of Measurement of Pharmaceutical Particles Size and Their Restrictions, Chem. Listy 2014, 108 (1) 50-55.

Šimek M., Grünwaldová V., Kratochvíl B.: Hot-Stage Microscopy for Determination of API Particles in a Formulated Tablet, BioMed Res. Int. 2014, Article ID 832452

Sládková V., Skalická T., Skořepová E., Eigner V., Čejka J., Kratochvíl B.; Systematic solvate screening of trospium chloride: discovering hydrates of a long-established pharmaceutical, CrystEngComm, 2015,17, 4712-4721.

Sládková, V.; Cibulková, J.; Eigner, V.; Šturc, A.; Kratochvíl, B.; Rohlíček, J. Application and Comparison of Cocrystallization Techniques on Trospium Chloride Cocrystals. Crystal Growth and Design 2014, 14 (6), 2931–2936. 

Sládková, V.; Kratochvíl, B.; Krasnokutskaya, E. Kokrystalizační screening: výhody a úskalí jednotlivých kokrystalizačních technik. Chem. Listy 2014, 11.

Šimek M., Grünwaldová V., Kratochvíl B.: Hot-stage microscopy for Determination of API fragmentation: Comparison with other methods. Pharm. Dev. Technol., 2015 early online 1-7

Šimek M., Kratochvíl B.: Mikroskopie s vyhřívaným stolkem ve farmaceutickém průmyslu, Chem. Listy2015, 109 (9) 687-692.

Šimek M., Vyňuchal J., Tomášová L.: Kneading: Alternative sizing of active pharmaceutical ingredients?,Pharm. Dev. Technol. 2015, early online 1-7.

Aktualizováno: 7.4.2021 15:04, Autor: Jan Čejka

VŠCHT Praha
Technická 5
166 28 Praha 6 – Dejvice
IČO: 60461373
DIČ: CZ60461373

Datová schránka: sp4j9ch

Copyright VŠCHT Praha 2014
Za informace odpovídá Oddělení komunikace, technický správce Výpočetní centrum

zobrazit mobilní verzi